Metraipolis › archive › dc_551cd232a5a9
MTUS2-AS1 suppression promotes DDX5 protein degradation to enhance the sensitivity of PARP inhibitors in BRCA-wild triple negative breast cancer — Europe PMC PMID:42524562
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42524562
- DOI
- 10.7150/ijbs.133410
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T03:27:32.839Z
- SHA-256 of the archived text
dafacf54db70067663849c59f87933da8c4be5f7267d387828b4c8cadbc0736c- Stable URL of this page
https://metraipolis.com/documento/dc_551cd232a5a9
How to cite
MTUS2-AS1 suppression promotes DDX5 protein degradation to enhance the sensitivity of PARP inhibitors in BRCA-wild triple negative breast cancer — Europe PMC PMID:42524562 — Europe PMC (en), https://europepmc.org/article/MED/42524562 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_551cd232a5a9 (Metraipolis archive dc_551cd232a5a9, sha256 dafacf54db70067663849c59f87933da8c4be5f7267d387828b4c8cadbc0736c)
BibTeX
@misc{dc551cd232a5a9,
title = {MTUS2-AS1 suppression promotes DDX5 protein degradation to enhance the sensitivity of PARP inhibitors in BRCA-wild triple negative breast cancer — Europe PMC PMID:42524562},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42524562},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_551cd232a5a9; sha256 dafacf54db70067663849c59f87933da8c4be5f7267d387828b4c8cadbc0736c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42524562. Agents can read the archived copy with the MCP tool read_document.